Reckitt to pay $1.4B in opioid settlement

Reckitt Benckiser Group will pay up to $1.4 billion to settle U.S. investigations into whether its former pharma unit organized a multibillion-dollar fraud to drive up sales of its opioid-addiction treatment, Suboxone. (Source: PharmaManufacturing.com)